Fosigotifator by Calico Life Sciences for Unspecified Central Nervous System Disorders: Likelihood of Approval
Fosigotifator is under clinical development by Calico Life Sciences and currently in Phase II for Unspecified Central Nervous System Disorders.
Fosigotifator is under clinical development by Calico Life Sciences and currently in Phase II for Unspecified Central Nervous System Disorders.
What's Your Reaction?
